Trial
NCT05247307
Efficacy of the Infusion of Donor Plasma in COVID-19 Infection
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Hospital Galdakao-Usansolo
Collaborators
—
Condition
COVID-19
Intervention
convalescent plasma infusion covid 19
Why stopped
Lack of efficacy of treatment tested
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-07